Purchase Order 75F40123P00063
- Not listed
- The Food and Drug Administration awarded a $22,964.38 firm fixed-price delivery order to Agilent Technologies Inc. on July 24, 2024, for an Agilent workstation and software upgrade to be completed by September 25, 2025. The contract, which carries no set-aside designation, is being performed at a location in Marshtonville, Delaware, and represents a task order under Agilent's Multiple Award Schedule contract vehicle with the federal government. This delivery order falls within Agilent's...
- This is a firm fixed-price purchase order for $23,783.08 awarded by the Food and Drug Administration (FDA) to Agilent Technologies Inc., Customer Service and Sales Division, a subsidiary of the parent company Agilent Technologies, Inc. The contract is for the upgrade of an OpenLab LC ChemStation system, with a completion date of September 22, 2024. Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets, providing a wide range of analytical...
- The Food and Drug Administration awarded a $65,523 firm fixed-price purchase order to Agilent Technologies Inc. on June 29, 2021, for software update and qualification services related to OpenLab Chromatography Data System (CDS) and Electronic Compliance Management (ECM) software. The contract is scheduled for completion by July 5, 2022, with performance at the FDA's Silver Spring, Maryland facility. This award was made without set-aside designation, indicating full and open competition. Agilent...
- This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc. The $113,616.84 purchase order is for a firm fixed price contract with a completion date of November 18, 2022. The contract does not have a set-aside designation. Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets, providing...
- The Food and Drug Administration awarded a $188,012.26 delivery order to Agilent Technologies Inc. for maintenance and support services related to OpenLab CDS (Chromatography Data System) and ECM (Enterprise Content Management) software. The contract, issued on September 10, 2025, with an ultimate completion date of September 10, 2026, represents a firm fixed-price engagement under a Multiple Award Schedule vehicle. The work will be performed in Brinklow, Maryland, supporting FDA's laboratory...
- This $45,092.22 firm fixed price delivery order contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Agilent Technologies Inc. for the provision of mass spectrometer components. The contract does not have a set-aside designation. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing advanced analytical instruments, software, services, and consumables to federal agencies. Through its Customer Service...
- The Food and Drug Administration awarded a $191,011.32 delivery order to Agilent Technologies Inc.'s Customer Service and Sales division on March 16, 2020, for corrective, remedial repair, and preventive maintenance services on Agilent 6550 Time-of-Flight Quadrupole Time-of-Flight (QTOF) mass spectrometry and Agilent 1290 Ultra-Performance Liquid Chromatography (UPLC) systems. The contract, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by...
- Agilent Technologies Inc.'s Customer Service and Sales Division received a $220,157.38 delivery order from the Food and Drug Administration for laboratory equipment on August 11, 2017, with an ultimate completion date of October 10, 2018. This firm fixed-price contract was awarded without set-aside designation and is performed at a location in Berwyn Heights, Maryland. The award represents a task order under the Scientific Equipment and Services (FSS-66) General Services Administration...
- Agilent Technologies, Inc. (Santa Clara Site) received a delivery order award from the Food and Drug Administration (FDA) on September 18, 2014, for an OpenLab ChemStation upgrade with a firm fixed price ceiling value of $14,299.44. The delivery order was placed under the General Services Administration Schedule 66 for Scientific Equipment and Services, representing a continuation of the existing master contract vehicle. No set-aside designation was used for this award, indicating full and...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Agilent Technologies Inc. (Customer Service and Sales Division) on August 3, 2022, for a headspace sampler with a ceiling value of $32,625.65 and an ultimate completion date of May 17, 2023. The award was performed in Irvine, California, with no set-aside designation, indicating full and open competition. Agilent Technologies, a global leader in analytical instrumentation headquartered in Santa Clara, California,...
The Food and Drug Administration awarded a $18,089.86 firm fixed-price purchase order to Agilent Technologies, Inc. (Santa Clara Site division) on March 15, 2023, for an Agilent software upgrade. The contract was awarded without a set-aside designation through full and open competition and is scheduled for ultimate completion on March 19, 2024. The place of performance is located in Calverton, Maryland. As a leading provider of analytical instruments and laboratory solutions, Agilent Technologies regularly supplies scientific equipment and specialized software to federal agencies across multiple departments, positioning the company as a key vendor for laboratory modernization and maintenance initiatives. This purchase order supports the FDA's laboratory operations and analytical capabilities by providing essential software upgrades to existing Agilent instrumentation. The relatively modest contract value reflects the specialized nature of software licensing and upgrade services for scientific analytical equipment. Agilent's extensive history of federal contracting, particularly with health and scientific agencies, demonstrates the company's established role in supporting government laboratory infrastructure and analytical operations critical to the FDA's regulatory and research missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.1k | 3/14/23 |